{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-027464","form_type":"8-K","ticker":"PULM","cik":"0001574235","company_name":"Pulmatrix, Inc.","filed_at":"2023-08-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.395124+00:00","generated_at":"2026-06-11T17:33:12.506972+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Pulmatrix Q2 2023: cash $25.8M, net loss $3.8M; PUR1900 Phase 2b enrollment ongoing, topline Q3 2024","bullets":["Cash and cash equivalents $25.8M as of June 30, 2023; projected runway into Q1 2025.","Q2 revenue $1.8M (up from $1.3M YoY); net loss $3.8M ($1.04 per share).","PUR1900 Phase 2b for ABPA enrolling; 13 sites active; topline data expected Q3 2024.","IND filed for PUR3100 Phase 2 in acute migraine; partnership needed to start trial.","Phase 1b data for PUR1800 in AECOPD presented; partnership opportunities being pursued."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-027464","json":"https://secwatch.observer/filing/0001493152-23-027464.json","markdown":"https://secwatch.observer/filing/0001493152-23-027464.md","text":"https://secwatch.observer/filing/0001493152-23-027464.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1574235/000149315223027464/0001493152-23-027464-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1574235/000149315223027464/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T17:33:12.506972+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c1d1bc8aa807dd72e17054e8e1e698d8627ec9e4","claim":"Pulmatrix, Inc. reported financial results for the second fiscal quarter ended June 30, 2023.","evidence_excerpt":"On August 10, 2023, Pulmatrix, Inc. issued a press release announcing its financial results for the second fiscal quarter ended June 30, 2023 and provided a corporate update.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1574235/000149315223027464/0001493152-23-027464-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the second fiscal quarter ended June 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}